Articles

Tabersonine affects osteoclast differentiation, apoptosis and ameliorates bone loss in osteoporotic mice

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 November 2026
14
Views
10
Downloads

Authors

This study investigates the effects of tabersonine on osteoclast differentiation, apoptosis, and bone loss in osteoporotic mice. To address these objectives, we performed a series of in vitro and in vivo experiments. In vitro, RAW264.7 cell viability was assessed using the CCK-8 method, and osteoclast-like cells were induced with RANKL. The impact of tabersonine on osteoclast-like cell differentiation was assessed via TRAP staining, while DAPI and TRITC-Phalloidin staining were used to examine nuclear morphology and actin filament organization. Apoptosis in mature osteoclast-like cells was evaluated using Hoechst 33258 staining, and intracellular ROS levels were measured using a commercial assay kit. The expression of genes associated with osteoclast differentiation and apoptosis was analyzed by quantitative real-time PCR, and corresponding protein levels were determined via Western blotting. In vivo, an osteoporosis mouse model was established and treated with tabersonine. The femurs were collected and subjected to micro-CT reconstruction, H&E staining, and TRAP staining to evaluate the extent of bone loss. The results demonstrated that in vitro, tabersonine significantly inhibited osteoclast-like cell differentiation, accompanied by reduced expression of key differentiation-related genes, including MMP-9 and NFATc1, and altered activation of differentiation-associated proteins such as NFATc1, C-Fos, and C-Jun. Furthermore, tabersonine promoted apoptosis in mature osteoclast-like cells, as evidenced by upregulated apoptosis-related genes (Caspase-3 and Bax) and proteins (Caspase-3, Bax, Bcl-2, and Caspase-9). In vivo, tabersonine ameliorated bone loss parameters and reduced osteoclast numbers in femoral tissues of osteoporotic mice. Collectively, these findings suggest that tabersonine suppresses osteoclast-like cell differentiation and facilitates apoptosis of mature osteoclast-like cells, thereby effectively attenuating bone loss in osteoporotic mice.

Downloads

Download data is not yet available.

Citations

1. Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med 2024;177:ITC1-ITC16. DOI: https://doi.org/10.7326/AITC202401160
2. Walker MD, Shane E. Postmenopausal osteoporosis. N Engl J Med 2023;389:1979-91. DOI: https://doi.org/10.1056/NEJMcp2307353
3. Foessl I, Dimai HP, Obermayer-Pietsch B. Long-term and sequential treatment for osteoporosis. Nat Rev Endocrinol 2023;19:520-33. DOI: https://doi.org/10.1038/s41574-023-00866-9
4. Stegen S, Carmeliet G. Metabolic regulation of skeletal cell fate and function. Nat Rev Endocrinol 2024;20:399-413. DOI: https://doi.org/10.1038/s41574-024-00969-x
5. Takegahara N, Kim H, Choi Y. Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases. Exp Mol Med 2024;56:264-72. DOI: https://doi.org/10.1038/s12276-024-01157-7
6. Stegen S, Moermans K, Stockmans I, Thienpont B, Carmeliet G. The serine synthesis pathway drives osteoclast differentiation through epigenetic regulation of NFATc1 expression. Nat Metab 2024;6:141-52. DOI: https://doi.org/10.1038/s42255-023-00948-y
7. Dong Y, Kang H, Peng R, Liu Z, Liao F, Hu SA, et al. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis. Cell Metab 2024;36:1679-95.e6. DOI: https://doi.org/10.1016/j.cmet.2024.03.005
8. Li Z, Li D, Chen R, Gao S, Xu Z, Li N. Cell death regulation: A new way for natural products to treat osteoporosis. Pharmacol Res 2023;187:106635. DOI: https://doi.org/10.1016/j.phrs.2022.106635
9. Chen S, Jin J, Xu Z, Han H, Wu L, Li Z. Catalpol attenuates osteoporosis in ovariectomized rats through promoting osteoclast apoptosis via the Sirt6-ERα-FasL axis. Phytomedicine 2024;123:155262. DOI: https://doi.org/10.1016/j.phymed.2023.155262
10. Reid IR. A broader strategy for osteoporosis interventions. Nat Rev Endocrinol 2020;16:333-9. DOI: https://doi.org/10.1038/s41574-020-0339-7
11. Etit D, Ögmundarson Ó, Zhang J, Krogh Jensen M, Sukumara S. Early-stage economic and environmental impact assessment for optimized bioprocess development: Monoterpenoid indole alkaloids. Bioresour Technol 2024;391:130005. DOI: https://doi.org/10.1016/j.biortech.2023.130005
12. Qian C, Wang J, Lin W, Chen Y, Yang J, Liu M, et al. Tabersonine attenuates obesity-induced renal injury via inhibiting NF-κB-mediated inflammation. Phytother Res 2023;37:2353-63. DOI: https://doi.org/10.1002/ptr.7756
13. Xu HW, Li WF, Hong SS, Shao JJ, Chen JH, Chattipakorn N, et al. Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice. Acta Pharmacol Sin 2023;44:1252-61. DOI: https://doi.org/10.1038/s41401-022-01040-z
14. Chen Y, Lin W, Chen P, Ye B, Luo W, Wang X, et al. Tabersonine alleviates obesity-induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1-mediated inflammation. Phytother Res 2023;37:860-71. DOI: https://doi.org/10.1002/ptr.7666
15. Sun X, Gan L, Li N, Sun S, Li N. Tabersonine ameliorates osteoblast apoptosis in rats with dexamethasone-induced osteoporosis by regulating the Nrf2/ROS/Bax signalling pathway. AMB Express 2020;10:165. DOI: https://doi.org/10.1186/s13568-020-01098-0
16. Komori T. Animal models for osteoporosis. Eur J Pharmacol 2015;759:287-94. DOI: https://doi.org/10.1016/j.ejphar.2015.03.028
17. Mu CR. Preparation and optimization of paraffin sections. New Discovery 2025;4:33-6. DOI: https://doi.org/10.61958/NDBL5726
18. Zhang D, Li X, Hu Y, Jiang H, Wu Y, Ding Y, et al. Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. Biochem Pharmacol 2018;154:183-92. DOI: https://doi.org/10.1016/j.bcp.2018.05.004
19. Hayman AR. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 2008;41:218-23. DOI: https://doi.org/10.1080/08916930701694667
20. Veis DJ, O'Brien CA. Osteoclasts, master sculptors of bone. Annu Rev Pathol 2023;18:257-81. DOI: https://doi.org/10.1146/annurev-pathmechdis-031521-040919
21. Jung SY, Min BM. A vitronectin-derived dimeric peptide suppresses osteoclastogenesis by binding to c-Fms and inhibiting M-CSF signaling. Exp Cell Res 2022;418:113252. DOI: https://doi.org/10.1016/j.yexcr.2022.113252
22. Son A, Kang N, Oh SY, Kim KW, Muallem S, Yang YM, et al. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism. J Endocrinol 2019;242:241-9. DOI: https://doi.org/10.1530/JOE-19-0123
23. Mun SH, Park PSU, Park-Min KH. The M-CSF receptor in osteoclasts and beyond. Exp Mol Med 2020;521239-54. DOI: https://doi.org/10.1038/s12276-020-0484-z
24. Al Mamun MA, Asim MMH, Sahin MAZ, Al-Bari MAA. Flavonoids compounds from Tridax procumbens inhibit osteoclast differentiation by down-regulating c-Fos activation. J Cell Mol Med 2020;24:2542-51. DOI: https://doi.org/10.1111/jcmm.14948
25. Jiang T, Xia T, Qiao F, Wang N, Jiang Y, Xin H. Role and regulation of transcription factors in osteoclastogenesis. Int J Mol Sci 2023;24:16175. DOI: https://doi.org/10.3390/ijms242216175
26. Yang Q, Guo J, Zheng J, Chen Y, Zou B, Li R, et al. Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling. Int Immunopharmacol 2023;120:110316. DOI: https://doi.org/10.1016/j.intimp.2023.110316
27. Zhang L, Yang Y, Liao Z, Liu Q, Lei X, Li M, et al. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade. Theranostics 2020;10:6638-60. DOI: https://doi.org/10.7150/thno.44793
28. Nakagawa S, Omori K, Nakayama M, Mandai H, Yamamoto S, Kobayashi H, et al. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1. Int Immunopharmacol 2020;83:106429. DOI: https://doi.org/10.1016/j.intimp.2020.106429
29. Dominguez R, Holmes KC. Actin structure and function. Annu Rev Biophys. 2011;40:169-86. DOI: https://doi.org/10.1146/annurev-biophys-042910-155359
30. Lee BS. Myosins in osteoclast formation and function. Biomolecules 2018;8:157. DOI: https://doi.org/10.3390/biom8040157
31. Yuan L, Zhao N, Wang J, Liu Y, Meng L, Guo S, et al. Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition. Theranostics 2021;11:7247-61. DOI: https://doi.org/10.7150/thno.58468
32. Teitelbaum SL. The osteoclast and its unique cytoskeleton. Ann NY Acad Sci 2011;1240:14-7. DOI: https://doi.org/10.1111/j.1749-6632.2011.06283.x
33. Roux S, Lambert-Comeau P, Saint-Pierre C, Lépine M, Sawan B, Parent JL. Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochem Biophys Res Commun 2005;333:42-50. DOI: https://doi.org/10.1016/j.bbrc.2005.05.092
34. Tai TW, Chen CY, Su FC, Tu YK, Tsai TT, Lin CF, et al. Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells. Sci Rep 2017;7:44245. DOI: https://doi.org/10.1038/srep44245
35. Wong SW, Huang BW, Hu X, Ho Kim E, Kolb JP, Padilla RJ, et al. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease. Cell Death Differ 2020;27:71-84. DOI: https://doi.org/10.1038/s41418-019-0341-6
36. Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity 2019;50:1352-64. DOI: https://doi.org/10.1016/j.immuni.2019.05.020
37. Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol 2022;221:e202201159. DOI: https://doi.org/10.1083/jcb.202201159
38. Birkinshaw RW, Czabotar PE. The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation. Semin Cell Dev Biol 2017;72:152-62. DOI: https://doi.org/10.1016/j.semcdb.2017.04.001
39. Roux C, Briot K. Current role for bone absorptiometry. Joint Bone Spine 2017;84:35-7. DOI: https://doi.org/10.1016/j.jbspin.2016.02.032
40. Xiong Y, Huang CW, Shi C, Peng L, Cheng YT, Hong W, et al. Quercetin suppresses ovariectomy-induced osteoporosis in rat mandibles by regulating autophagy and the NLRP3 pathway. Exp Biol Med (Maywood) 2023;248:2363-80. DOI: https://doi.org/10.1177/15353702231211977
41. Chatterjee M, Faot F, Correa C, Kerckhofs J, Vandamme K. Is the jaw bone micro-structure altered in response to osteoporosis and bisphosphonate treatment? A micro-CT analysis. Int J Mol Sci 2021;22:6559. DOI: https://doi.org/10.3390/ijms22126559
42. Ryoo GH, Moon YJ, Choi S, Bae EJ, Ryu JH, Park BH. Tussilagone promotes osteoclast apoptosis and prevents estrogen deficiency-induced osteoporosis in mice. Biochem Biophys Res Commun 2020;531:508-14. DOI: https://doi.org/10.1016/j.bbrc.2020.07.083

Ethics Approval

All animal experiments were conducted in accordance with the approval of the Animal Experimentation Ethics Committee at Bengbu Medical University

CRediT authorship contribution

Hui Shi, writing – original draft, visualization, validation, software, resources, methodology, investigation, formal analysis, data curation, conceptualization, writing – review & editing. Pinghui Zhou, visualization, validation, software, resources, methodology, investigation, formal analysis, funding acquisition. Jingxian Fan, visualization, validation, software, resources. Zhihui Wang, visualization, resources, methodology, investigation. Chengfeng Xu, visualization, validation, software. Nan Zhang, software, resources. Shiying Bian, resources, investigation. Xu Weng, validation, software. Qin Yang, resources, methodology. Mengying Xu, resources, investigation. Xishuai Tong, visualization, validation. Yingxiao Fu, writing – original draft, visualization, validation, software, resources, methodology, investigation, formal analysis, data curation, writing – review & editing, supervision, funding acquisition, conceptualization, project administration.

Supporting Agencies

Project of Natural Science Foundation of Anhui Province, Natural Science Research Project of Anhui Provincial Department of Education , Project of Anhui Province Key Laboratory of Tissue Transplantation, Anhui Province College Students Innovation And Entrepreneurship Training Program

Data Availability Statement

The data used to support the findings of this study are available from the corresponding author on reasonable request

How to Cite



1.
Shi H, Zhou P, Fan J, Wang Z, Xu C, Zhang N, et al. Tabersonine affects osteoclast differentiation, apoptosis and ameliorates bone loss in osteoporotic mice. Eur J Histochem [Internet]. 2026 Nov. 20 [cited 2026 Nov. 22];70(4). Available from: https://www.ejh.it/ejh/article/view/4546